Preliminary report: hepatic fat and inflammation in type 2 diabetes mellitus

Metabolism. 2010 Mar;59(3):430-2. doi: 10.1016/j.metabol.2009.07.041. Epub 2009 Oct 21.

Abstract

Although the association between inflammation and hepatic fat is fairly established, it remains unclear whether this association is independent of general measures of obesity and standard cardiovascular risk factors. Therefore, the aim of this study was to investigate the contribution of hepatic steatosis as an independent predictor of chronic inflammation in 281 subjects with type 2 diabetes mellitus. Reduced hepatic steatosis significantly (P < .01) correlated with C-reactive protein (r = -0.16) and adiponectin (r = 0.23). The association of hepatic steatosis with both C-reactive protein and adiponectin remained significant after adjustment for age, ethnicity, body mass index (or waist circumference), triglycerides, high-density lipoprotein, and total cholesterol. These data support the concept that accumulation of hepatic fat is related to enhanced inflammation in type 2 diabetes mellitus independent of general measures of obesity and standard cardiovascular risk factors.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Adiponectin / blood
  • Adipose Tissue / pathology*
  • Adult
  • Body Mass Index
  • C-Reactive Protein / metabolism
  • Diabetes Mellitus, Type 2 / complications*
  • Diabetes Mellitus, Type 2 / pathology*
  • Fatty Liver / etiology
  • Fatty Liver / pathology
  • Female
  • Hepatitis / etiology*
  • Hepatitis / pathology*
  • Humans
  • Interleukin-6 / blood
  • Lipid Metabolism / physiology
  • Lipids / blood
  • Liver / pathology*
  • Male
  • Middle Aged
  • Obesity / complications
  • Obesity / pathology
  • Risk Factors

Substances

  • Adiponectin
  • Interleukin-6
  • Lipids
  • C-Reactive Protein